Pacira Pharmaceuticals (PCRX) PT Raised to 'Street High' $75 at Jefferies; Surveys Boosts Confidence in Exparel
Tweet Send to a Friend
Jefferies analyst David Steinberg raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to a 'Street High' $75.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
